ATF3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.256400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.837580E-01
Normal-vs-Stage2
3.249000E-01
Normal-vs-Stage3
5.608500E-02
Normal-vs-Stage4
1.656050E-01
Stage1-vs-Stage2
6.980600E-01
Stage1-vs-Stage3
6.103000E-01
Stage1-vs-Stage4
2.860600E-01
Stage2-vs-Stage3
6.523300E-03
Stage2-vs-Stage4
1.392580E-01
Stage3-vs-Stage4
2.347800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.329200E-01
Normal-vs-AfricanAmerican
2.438400E-01
Normal-vs-Asian
3.001400E-01
Caucasian-vs-AfricanAmerican
2.551200E-01
Caucasian-vs-Asian
6.059800E-01
AfricanAmerican-vs-Asian
3.178600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.329600E-01
Normal-vs-Female
3.134000E-01
Male-vs-Female
3.062200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.669000E-01
Normal-vs-Age(41-60Yrs)
2.203400E-01
Normal-vs-Age(61-80Yrs)
3.915400E-01
Normal-vs-Age(81-100Yrs)
4.195400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.058800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.532800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.568200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.861600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.824230E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.874200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.099600E-01
Normal-vs-Daily Drinker
2.793800E-01
Normal-vs-Weekly Drinker
4.156800E-01
Normal-vs-Occasional Drinker
4.733600E-01
Normal-vs-Social Drinker
6.047600E-01
Non Drinker-vs-Daily Drinker
9.482800E-01
Non Drinker-vs-Weekly Drinker
5.449600E-01
Non Drinker-vs-Occasional Drinker
3.579400E-01
Non Drinker-vs-Social Drinker
9.116000E-02
Daily Drinker-vs-Weekly Drinker
4.345000E-01
Daily Drinker-vs-Occasional Drinker
3.019000E-01
Daily Drinker-vs-Social Drinker
5.705800E-02
Weekly Drinker-vs-Occasional Drinker
8.530200E-01
Weekly Drinker-vs-Social Drinker
3.376400E-01
Occasional Drinker-vs-Social Drinker
4.375800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.034400E-01
Normal-vs-Grade 2
3.587400E-01
Normal-vs-Grade 3
3.929400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.018900E-04
Grade 1-vs-Grade 3
1.703500E-02
Grade 1-vs-Grade 4
6.034400E-01
Grade 2-vs-Grade 3
3.872600E-01
Grade 2-vs-Grade 4
3.587400E-01
Grade 3-vs-Grade 4
3.929400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.346000E-01
Normal-vs-NonDiabetic
3.783400E-01
Diabetic-vs-NonDiabetic
4.256400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.419200E-01
Normal-vs-NoPancreatitis
3.797000E-01
Pancreatitis-vs-NoPancreatitis
1.387350E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.367600E-01
Normal-vs-N1
3.203600E-01
N0-vs-N1
4.593800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.359200E-01
Normal-vs-TP53-NonMutant
7.499000E-01
TP53-Mutant-vs-TP53-NonMutant
1.839160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
